Detalles de la búsqueda
1.
Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
Catheter Cardiovasc Interv
; 86(6): E229-38, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25946686
2.
ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study.
Postepy Kardiol Interwencyjnej
; 16(2): 153-161, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32636899
3.
ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study.
Int J Cardiol
; 227: 478-484, 2017 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825727
4.
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
EuroIntervention
; 12(2): e224-34, 2016 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27290681
5.
Coronary stenosis and left ventricular function - Major prognostic factors in patients with ischemic heart disease: Has something changed in the era of "precision medicine"?
Int J Cardiol
; 278: 36-37, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545618
Resultados
1 -
5
de 5
1
Próxima >
>>